Vertex Pharmaceuticals (VRTX) Shares Issued (2009 - 2012)
Vertex Pharmaceuticals' (VRTX) quarterly Shares Issued came in at $1.2 million in Q3 2012, up 266.88% year-on-year from $317000.0 in Q4 2011, and up 237.1% quarter-over-quarter from $345000.0 in Q2 2012.
Vertex Pharmaceuticals (VRTX) Shares Issued (2009 - 2012) Analysis & Trends
Vertex Pharmaceuticals' Shares Issued history runs 4 years deep, the most recent figure standing at $1.2 million for Q3 2012.
- On a quarterly basis, Shares Issued rose 266.88% year-over-year to $1.2 million in Q3 2012; TTM through Sep 2012 was $1.2 million, a 266.88% increase from a year earlier, with the FY2011 full-year figure at $8.6 million, down 59.46% from the prior year.
- Shares Issued grew to $1.2 million in Q3 2012 per VRTX's latest filing, from $345000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $21.3 million in Q4 2010 and bottomed at $317000.0 in Q3 2011.
- The 4-year median for Shares Issued is $2.4 million (2011), against an average of $6.9 million.
- Biggest YoY gain for Shares Issued was 266.88% in 2012; the steepest drop was 88.86% in 2012.
- Year by year, Shares Issued stood at $19.2 million in 2009, then increased by 10.72% to $21.3 million in 2010, then plunged by 59.46% to $8.6 million in 2011, then plunged by 86.53% to $1.2 million in 2012.
- Per Business Quant, the three latest VRTX Shares Issued figures stand at $1.2 million (Q3 2012), $345000.0 (Q2 2012), and $403000.0 (Q1 2012).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 88,604.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.44 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 1.16 Mn |
| Sep 30, 2012 | 1.16 Mn |
| Jun 30, 2012 | 345,000.00 |
| Jun 30, 2012 | 345,000.00 |
| Mar 31, 2012 | 403,000.00 |
| Mar 31, 2012 | 403,000.00 |
| Dec 31, 2011 | 8.63 Mn |
| Dec 31, 2011 | 8.63 Mn |
| Sep 30, 2011 | 317,000.00 |
| Sep 30, 2011 | 317,000.00 |
| Mar 31, 2011 | 3.62 Mn |
| Mar 31, 2011 | 3.62 Mn |
| Dec 31, 2010 | 21.29 Mn |
| Dec 31, 2010 | 21.29 Mn |
| Dec 31, 2009 | 19.23 Mn |
| Dec 31, 2009 | 19.23 Mn |